Latest news from ProtonDx
ProtonDx welcomes new CFO, Ann Wong, to drive scale-up and commercial expansion
Thu, March 16th 2023
• Ann Wong brings extensive experience of scaling organisations and leading finance operations
Read article
Dragonfly Respiratory Panel reliably identifies five most common causes of respiratory infections, joins list of UK approved diagnostic products
Mon, February 6th 2023
• Rapid molecular point-of-care diagnostic system reliably detects SARS-CoV-2, Flu A, Flu B, RSV and Human Rhinovirus • Clinical test results for CTDA validation achieved 100% sensitivity and 100% specificity • UK approval follows CE-IVD mark
Read article
ProtonDx and Katalyst announce strategic partnership to distribute Dragonfly in vitro diagnostic
Mon, January 9th 2023
• Exclusive rights to distribute CE-IVD marked Dragonfly diagnostic system in key client segments. • Dragonfly System able to detect five common respiratory pathogens at once.
Read article
ProtonDx Revs Up European Commercial Expansion with New Head of Sales
Thu, December 15th 2022
• Leigh Howes brings more than 20 years diagnostics sector experience • Track record of commercial success across Europe
Read article
The respiratory infection season – multiple infections, multiple detection
Mon, December 12th 2022
Assistant Professor Jesus Rodriguez Manzano, Co-Founder and CSO at ProtonDx, and Deputy Director of the Centre for Antimicrobial Optimisation (CAMO) at Imperial College, shares his views on the current threat of a ‘tripledemic’ that looms over the Northern hemisphere, including many parts of Europe.
Read article
ProtonDx awarded £365,000 Defra and Innovate UK grant to develop Porcine Lung Disease diagnostic
Fri, September 23rd 2022
• Grant to develop automated, rapid point-of-need diagnostic to provide a sustainable and resilient revolution in detection and diagnosis of Porcine Respiratory Disease Complex (PRDC) • Working in collaboration with Imperial College, farmers and industry experts to help address the global issue of rising antibiotic resistance
Read article
Diagnostics are at the heart of a global AMR solution
Wed, September 14th 2022
Opinion article: Dr Jesus Rodriguez-Manzano, Co-Founder and Chief Scientific Officer (CSO) at ProtonDx, shares his thoughts on anti-microbial resistance (AMR). He discusses what we can learn from the recent COVID‑19 pandemic, including the important role that point-of-need diagnostics can play.
Read article
ProtonDx’s Dragonfly Diagnostic System successfully deployed at the 2022 Commonwealth Games
Tue, August 30th 2022
5-in-1 Respiratory Test Panel from ProtonDx used to assess elite athletes at the 2022 Commonwealth Games
Read article
New Rapid Multi-Viral Diagnostic Kit Receives CE-IVD Mark
Tue, June 21st 2022
Dragonfly™ detects SARS-CoV-2, Flu A, Flu B, RSV and human rhinovirus without a lab. It is a cost-effective point-of-need portable diagnostic system for infectious disease now commercially available.
Read article
ProtonDx tackles malaria diagnosis
Fri, April 29th 2022
Lacewing, the futuristic lab-on-a-chip, diagnostic tool is one of eight initiatives promoted by Imperial College London to mark Malaria Day, 25 April, in order to demonstrate the College’s deep commitment to conquering malaria. Lacewing is being developed for health care applications by Imperial spin out company ProtonDx based at the College’s Translation and Innovation HUB (I-HUB), White City Campus.
Read article
Dragonfly goes Olympic
Tue, April 26th 2022
The Dragonfly Respiratory Diagnostic Panel was utilised by the Team GB clinical staff with great success to test Great Britain's athletes at the 2022 Olympic Winter Games in Beijing.
Read article
Higher risk for patients with flu and Covid-19
Mon, March 28th 2022
People infected by Covid-19 and influenza face four times the risk of requiring a ventilator and twice the risk of death. Diagnosis of which respiratory viruses are infecting the patient is crucial especially as there is no increased risk of severe illness for those with both Covid-19 and RSV or other respiratory viruses.
Read article
Lateral flow tests found wanting
Tue, March 1st 2022
Research by Imperial College London suggests that lateral flow tests miss a substantial number of COVID-19 infections, particularly for people without symptoms emphasising the need for rapid, sensitive, accurate and portable tests.
Read article
Antimicrobial Resistance crisis needs better diagnostics
Tue, February 22nd 2022
“Better, faster diagnostics will be central to tackling Antimicrobial Resistance in the future,” said ProtonDx Founder & Director, Asst Professor Jesus Rodriguez-Manzano, at a recent FORUM event organised by the Academy of Medical Sciences
Read article
ProtonDx CEO award for inspiration
Mon, December 20th 2021
ProtonDx CEO, Professor Pantelis Georgiou has won an award for his inspirational work from his colleagues in the Department of Electrical and Electronic Engineering, Imperial College London
Read article
Imperial Biomedical hub officially opened
Mon, December 6th 2021
ProtonDx is privileged to have secured office space in the prestigious Translation and Innovation Hub (IHUB) at White City campus of Imperial College London.
Read article
Best of British recognises ProtonDx
Thu, September 23rd 2021
The work of the ProtonDx team has been recognized in Best of British a government publication produced jointly with Malaria NO MORE.
Read article
ProtonDx CEO appointed Professor of Biomedical Electronics
Wed, September 22nd 2021
CEO of ProtonDx, Dr Pantelis Georgiou, was promoted to Professor of Biomedical Electronics in the annual promotion round at Imperial College London, one of only six to achieve this accolade this year.